Open Access Repository (ePrints)
Items where Author is "Hostrup, M"
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 14.
Article
Breenfeldt Andersen, A, Jacobson, GA 
ORCID: 0000-0002-3409-8769, Bejder, J, Premilovac, D ORCID: 0000-0003-2770-4713, Richards, SM ORCID: 0000-0002-5988-0423, Rasmussen, JJ, Jessen, S and Hostrup, M 2021
, 'An abductive inference approach to assess the performance‑enhancing effects of drugs included on the World Anti‑Doping Agency Prohibited List'
, Sports Medicine
, doi: https://doi.org/10.1007/s40279-021-01450-9.
ORCID: 0000-0002-3409-8769, Bejder, J, Premilovac, D ORCID: 0000-0003-2770-4713, Richards, SM ORCID: 0000-0002-5988-0423, Rasmussen, JJ, Jessen, S and Hostrup, M 2021
, 'An abductive inference approach to assess the performance‑enhancing effects of drugs included on the World Anti‑Doping Agency Prohibited List'
, Sports Medicine
, doi: https://doi.org/10.1007/s40279-021-01450-9.
Breenfeldt Andersen, A, Jacobson, GA ORCID: 0000-0002-3409-8769, Bejder, J, Premilovac, D ORCID: 0000-0003-2770-4713, Richards, SM ORCID: 0000-0002-5988-0423, Rasmussen, JJ, Jessen, S and Hostrup, M 2021
, 'An abductive inference approach to assess the performance‑enhancing effects of drugs included on the World Anti‑Doping Agency Prohibited List'
, Sports Medicine
, doi: https://doi.org/10.1007/s40279-021-01450-9.
ORCID: 0000-0002-3409-8769, Bejder, J, Premilovac, D ORCID: 0000-0003-2770-4713, Richards, SM ORCID: 0000-0002-5988-0423, Rasmussen, JJ, Jessen, S and Hostrup, M 2021
, 'An abductive inference approach to assess the performance‑enhancing effects of drugs included on the World Anti‑Doping Agency Prohibited List'
, Sports Medicine
, doi: https://doi.org/10.1007/s40279-021-01450-9.
Eibye, K, Jacobson, GA ORCID: 0000-0002-3409-8769, Bengtsen, K, Jessen, S, Backer, V, Bangsbo, J and Hostrup, M 2021
, 'Effect of one-week oral or inhaled salbutamol treatment with washout on repeated sprint performance in trained subjects'
, Translational Sports Medicine, vol. 4
, 241–249
, doi: https://doi.org/10.1002/tsm2.210.
ORCID: 0000-0002-3409-8769, Bengtsen, K, Jessen, S, Backer, V, Bangsbo, J and Hostrup, M 2021
, 'Effect of one-week oral or inhaled salbutamol treatment with washout on repeated sprint performance in trained subjects'
, Translational Sports Medicine, vol. 4
, 241–249
, doi: https://doi.org/10.1002/tsm2.210.
Eibye, K, Jacobson, GA ORCID: 0000-0002-3409-8769, Bengtsen, K, Jessen, S, Backer, V, Bangsbo, J and Hostrup, M 2021
, 'Effect of one-week oral or inhaled salbutamol treatment with washout on repeated sprint performance in trained subjects'
, Translational Sports Medicine, vol. 4
, 241–249
, doi: https://doi.org/10.1002/tsm2.210.
ORCID: 0000-0002-3409-8769, Bengtsen, K, Jessen, S, Backer, V, Bangsbo, J and Hostrup, M 2021
, 'Effect of one-week oral or inhaled salbutamol treatment with washout on repeated sprint performance in trained subjects'
, Translational Sports Medicine, vol. 4
, 241–249
, doi: https://doi.org/10.1002/tsm2.210.
Hostrup, M, Jacobson, GA ORCID: 0000-0002-3409-8769, Jessen, S and Krogh Lemminger, A 2020
, 'Anabolic and lipolytic actions of beta2-agonists in humans and antidoping challenges'
, Drug Testing and Analysis, vol. 12, no. 5
, 597–609
, doi: https://doi.org/10.1002/dta.2728.
ORCID: 0000-0002-3409-8769, Jessen, S and Krogh Lemminger, A 2020
, 'Anabolic and lipolytic actions of beta2-agonists in humans and antidoping challenges'
, Drug Testing and Analysis, vol. 12, no. 5
, 597–609
, doi: https://doi.org/10.1002/dta.2728.
Hostrup, M, Jacobson, GA ORCID: 0000-0002-3409-8769, Jessen, S and Krogh Lemminger, A 2020
, 'Anabolic and lipolytic actions of beta2-agonists in humans and antidoping challenges'
, Drug Testing and Analysis, vol. 12, no. 5
, 597–609
, doi: https://doi.org/10.1002/dta.2728.
ORCID: 0000-0002-3409-8769, Jessen, S and Krogh Lemminger, A 2020
, 'Anabolic and lipolytic actions of beta2-agonists in humans and antidoping challenges'
, Drug Testing and Analysis, vol. 12, no. 5
, 597–609
, doi: https://doi.org/10.1002/dta.2728.
Hostrup, M, Onslev, J, Jacobson, G ORCID: 0000-0002-3409-8769, Wilson, R ORCID: 0000-0003-0152-4394 and Bangsbo, J 2018
, 'Chronic β2-adrenoceptor agonist treatment alters muscle proteome and functional adaptations induced by high intensity training in young men'
, Journal of Physiology, vol. 596, no. 2
, pp. 231-252
, doi: https://doi.org/10.1113/JP274970.
ORCID: 0000-0002-3409-8769, Wilson, R ORCID: 0000-0003-0152-4394 and Bangsbo, J 2018
, 'Chronic β2-adrenoceptor agonist treatment alters muscle proteome and functional adaptations induced by high intensity training in young men'
, Journal of Physiology, vol. 596, no. 2
, pp. 231-252
, doi: https://doi.org/10.1113/JP274970.
Hostrup, M, Reitelseder, S, Jessen, S, Kalsen, A, Nyberg, M, Egelund, J, Kreiberg, M, Kristensen, CM, Thomassen, M, Pilegaard, H, Backer, V, Jacobson, GA ORCID: 0000-0002-3409-8769, Holm, L and Bangsbo, J 2018
, 'Beta2-adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men'
, Journal of Physiology, vol. 596, no. 17
, pp. 4121-4139
, doi: https://doi.org/10.1113/JP275560.
ORCID: 0000-0002-3409-8769, Holm, L and Bangsbo, J 2018
, 'Beta2-adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men'
, Journal of Physiology, vol. 596, no. 17
, pp. 4121-4139
, doi: https://doi.org/10.1113/JP275560.
Hostrup, M, Reitelseder, S, Jessen, S, Kalsen, A, Nyberg, M, Egelund, J, Kreiberg, M, Kristensen, CM, Thomassen, M, Pilegaard, H, Backer, V, Jacobson, GA ORCID: 0000-0002-3409-8769, Holm, L and Bangsbo, J 2018
, 'Beta2‐adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men'
, Journal of Physiology, vol. 596, no. 17
, pp. 4121-4139
, doi: https://doi.org/10.1113/JP275560.
ORCID: 0000-0002-3409-8769, Holm, L and Bangsbo, J 2018
, 'Beta2‐adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men'
, Journal of Physiology, vol. 596, no. 17
, pp. 4121-4139
, doi: https://doi.org/10.1113/JP275560.
Jacobson, GA ORCID: 0000-0002-3409-8769 and Hostrup, M 2020
, 'The salmeterol anomaly and the need for a urine threshold'
, Drug Testing and Analysis
, doi: https://doi.org/10.1002/dta.2810.
ORCID: 0000-0002-3409-8769 and Hostrup, M 2020
, 'The salmeterol anomaly and the need for a urine threshold'
, Drug Testing and Analysis
, doi: https://doi.org/10.1002/dta.2810.
Jacobson, GA ORCID: 0000-0002-3409-8769, Hostrup, M, Narkowicz, CK, Nichols, DS ORCID: 0000-0002-8066-3132 and Walters, EH ORCID: 0000-0002-0993-4374 2019
, 'Enantioselective disposition of (R,R)-formoterol, (S,S)-formoterol and their respective glucuronides in urine following single inhaled dosing and application to doping control'
, Drug Testing and Analysis
, doi: https://doi.org/10.1002/dta.2587.
ORCID: 0000-0002-3409-8769, Hostrup, M, Narkowicz, CK, Nichols, DS ORCID: 0000-0002-8066-3132 and Walters, EH ORCID: 0000-0002-0993-4374 2019
, 'Enantioselective disposition of (R,R)-formoterol, (S,S)-formoterol and their respective glucuronides in urine following single inhaled dosing and application to doping control'
, Drug Testing and Analysis
, doi: https://doi.org/10.1002/dta.2587.
Jacobson, GA ORCID: 0000-0002-3409-8769, Raidal, S, Hostrup, M, Calzetta, L, Wood-Baker, R, Farber, MO, Page, CP and Walters, EH ORCID: 0000-0002-0993-4374 2018
, 'Long-acting β2-agonists in asthma: enantioselective safety studies are needed'
, Drug Safety
, doi: https://doi.org/10.1007/s40264-017-0631-1.
ORCID: 0000-0002-3409-8769, Raidal, S, Hostrup, M, Calzetta, L, Wood-Baker, R, Farber, MO, Page, CP and Walters, EH ORCID: 0000-0002-0993-4374 2018
, 'Long-acting β2-agonists in asthma: enantioselective safety studies are needed'
, Drug Safety
, doi: https://doi.org/10.1007/s40264-017-0631-1.
Jessen, S, Solheim, SA, Jacobson, GA ORCID: 0000-0002-3409-8769, Eibye, K, Bangsbo, J, Nordsborg, NB and Hostrup, M 2020
, 'Beta2 -adrenergic agonist clenbuterol increases energy expenditure and fat oxidation, and induces mTOR phosphorylation in skeletal muscle of young healthy men'
, Drug Testing and Analysis, vol. 12, no. 5
, pp. 610-618
, doi: https://doi.org/10.1002/dta.2755.
ORCID: 0000-0002-3409-8769, Eibye, K, Bangsbo, J, Nordsborg, NB and Hostrup, M 2020
, 'Beta2 -adrenergic agonist clenbuterol increases energy expenditure and fat oxidation, and induces mTOR phosphorylation in skeletal muscle of young healthy men'
, Drug Testing and Analysis, vol. 12, no. 5
, pp. 610-618
, doi: https://doi.org/10.1002/dta.2755.
Onslev, J, Jacobson, G ORCID: 0000-0002-3409-8769, Narkowicz, C, Backer, V, Kalsen, A, Kreiberg, M, Jessen, S, Bangsbo, J and Hostrup, M 2017
, 'Beta2‑adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men'
, European Journal of Applied Physiology
, pp. 1-9
, doi: https://doi.org/10.1007/s00421-017-3679-9.
ORCID: 0000-0002-3409-8769, Narkowicz, C, Backer, V, Kalsen, A, Kreiberg, M, Jessen, S, Bangsbo, J and Hostrup, M 2017
, 'Beta2‑adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men'
, European Journal of Applied Physiology
, pp. 1-9
, doi: https://doi.org/10.1007/s00421-017-3679-9.